In summary, lnc-MX1-1 is a prognostic biomarker that, when combined with other biomarkers such as PSA and the PCA3 score, can be helpful in PCa diagnostics, prognostics and treatment, suggesting that a combination of genes and lncRNAs can be used in the clinic to get a prognosis panels. Here, PCA3 is linked to posterior cortical atrophy.